Search database
LIST OPTIONS
Filter
23
Filtered Results: 23
Text search: Drugs for Neglected Diseases initiative DNDi - Latin America
Featured
Language
Document type
Studies & Reports
13
Strategic & Response Plan
3
Guidelines
2
Fact sheets
2
Manuals
1
Resource Platforms
1
No document type
1
Countries / Regions
Latin America and the Carribbean
5
Global
3
Colombia
2
Brazil
1
Authors & Publishers
et al.
4
World Health Organization WHO
4
DNDi - Drugs for neglected diseases initiative
3
Forsyth, C.
3
Dahal, P.
2
Drugs for Neglected Diseases initiative DNDi
2
Drugs for Neglected Diseases initiative DNDi - Latin America
2
Avaria, A. et al.
1
Batista, C.
1
Bernal, O.
1
Chagas Coalition
1
DNDi Latin America
1
Drugs for Neglected Diseases Initiative DNDi Latin America
1
Fanjul, G.
1
Herazo, F.
1
Khan, J.
1
Maguire, B.
1
Maguire, B.J.
1
Marchiol, A
1
McGloin, J.
1
Médecins Sans Frontières
1
Moriana, S.
1
MSF Access Campaign
1
Oritz, G.
1
Pan American Health Organization PAHO
1
Pan American Journal of Public Health
1
PLOS Neglected Tropical Diseases
1
Rashan, S.
1
Rashan, S. et al.
1
Sanmatino, M.
1
Wamai, R.
1
World Health Organisation (WHO)
1
Zaidel, E.J.
1
Ziaggi, G.
1
Publication Years
Category
Countries
4
Clinical Guidelines
4
Pharmacy & Technologies
1
Toolboxes
NTDs
20
HIV
1
COVID-19
1
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand... more
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ... more
Overcoming barriers in low- and middle-income countries For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha... more